U
U.S. Dermatology Partners | Dermatology and Skin Cancer Center Leawood
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Rocatinlimab
Parent organization
This site is a part of U.S. Dermatology Partners
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 4 total trials
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Enrolling
Atopic Dermatitis
Drug: Rocatinlimab
Other: Placebo
The primary objective of this study is to assess successful self-administration of rocatinlimab subcutaneous using devices for injection at home.
Active, not recruiting
Atopic Dermatitis
Combination Product: Rocatinlimab AI
Combination Product: Rocatinlimab Prefilled Syringe
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems